The Biosimilar Hub is proudly brought to you by GBMA Education with funding from the Australian Government. It has been designed to help Australians better understand biosimilar medicines through the provision of independent, evidence-based information.
GBMA Education was awarded the Biosimilar Education Grant by the Australian Government in April 2018. The purpose of the Grant is to increase confidence in the use of biosimilar brands of biological medicines that are listed on the Pharmaceutical Benefits Scheme (PBS). Through the increased use of biosimilar medicines, the objective is to support a competitive market for biological medicines.
Materials developed for the Biosimilar Hub were developed in collaboration with representatives from across medical, pharmacy, medicines industry, consumer advocates and the Department of Health.
If you have any feedback or questions regarding the content, please submit your input here.
GBMA Education acknowledges the provision of funding by the Australian Government for the development and production of this educational website.